Correlation Between Intellia Therapeutics and Ginkgo Bioworks
Can any of the company-specific risk be diversified away by investing in both Intellia Therapeutics and Ginkgo Bioworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intellia Therapeutics and Ginkgo Bioworks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intellia Therapeutics and Ginkgo Bioworks Holdings, you can compare the effects of market volatilities on Intellia Therapeutics and Ginkgo Bioworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intellia Therapeutics with a short position of Ginkgo Bioworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intellia Therapeutics and Ginkgo Bioworks.
Diversification Opportunities for Intellia Therapeutics and Ginkgo Bioworks
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Intellia and Ginkgo is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Intellia Therapeutics and Ginkgo Bioworks Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ginkgo Bioworks Holdings and Intellia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intellia Therapeutics are associated (or correlated) with Ginkgo Bioworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ginkgo Bioworks Holdings has no effect on the direction of Intellia Therapeutics i.e., Intellia Therapeutics and Ginkgo Bioworks go up and down completely randomly.
Pair Corralation between Intellia Therapeutics and Ginkgo Bioworks
Given the investment horizon of 90 days Intellia Therapeutics is expected to generate 0.6 times more return on investment than Ginkgo Bioworks. However, Intellia Therapeutics is 1.65 times less risky than Ginkgo Bioworks. It trades about -0.05 of its potential returns per unit of risk. Ginkgo Bioworks Holdings is currently generating about -0.06 per unit of risk. If you would invest 4,336 in Intellia Therapeutics on August 31, 2024 and sell it today you would lose (2,774) from holding Intellia Therapeutics or give up 63.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Intellia Therapeutics vs. Ginkgo Bioworks Holdings
Performance |
| Timeline |
| Intellia Therapeutics |
| Ginkgo Bioworks Holdings |
Intellia Therapeutics and Ginkgo Bioworks Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intellia Therapeutics and Ginkgo Bioworks
The main advantage of trading using opposite Intellia Therapeutics and Ginkgo Bioworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intellia Therapeutics position performs unexpectedly, Ginkgo Bioworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will offset losses from the drop in Ginkgo Bioworks' long position.| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
| Ginkgo Bioworks vs. Ocean Biomedical | Ginkgo Bioworks vs. Enveric Biosciences | Ginkgo Bioworks vs. Hepion Pharmaceuticals | Ginkgo Bioworks vs. Elevation Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |